BioMarin CLN2 Results
“Intracerebroventricular cerliponase alpha (BMN 190) in children with CLN2 disease: [...]
Batten Researchers Lobel and Sleat Receive the Edison Patent Award for Their Work in CLN2
Rutgers Scientists Develop Therapy for Fatal Childhood Disease The R&D [...]
January 2016 Research News
2016 is going to be a big year for translational [...]
BDSRA Funds Crucial Project to Expand a Batten Disease Patient Registry
One of the most important steps toward finding effective medical [...]
Hope 4 Bridget Family Foundation Sees the Power of Partnership in Research and Finding a Cure
Bridget Kennicott was born on November 11, 2004, to proud [...]
StemCells, Inc. Announces Results of Long-Term Follow-Up Study in Batten Disease
Human Clinical Data Encompasses Five Years of Post-Transplant Safety NEWARK, [...]
Combination treatment in mice shows promise for fatal neurological disorder in kids
By Caroline Arbanas (March 15, 2012) Infants with Batten disease, [...]
Development of a Carrier Screening Test
A newly developed test could screen would-be parents for hundreds [...]
Highlights from Biomarin’s Research & Development Day
(Note: Below is an excerpt from BioMarin Pharmaceutical Inc.’s Press [...]
Mutations in DNAJC5
Autosomal-dominant adult-onset neuronal ceroid lipofuscinosis (ANCL) is characterized by accumulation [...]
